March 2024
1. WONG K, Pitcher D, Braddon F, Downward L, et al
   Effects of rare kidney diseases on kidney failure: a longitudinal analysis of the UK National Registry of Rare Kidney Diseases (RaDaR) cohort.
   Lancet. 2024;403:1279-1289.
   

   >> Share

   
   January 2024
2. KEARNEY N, Stefanovic N, Roche M
   Ultraviolet radiation manicure-related keratinocyte malignancies in a renal transplant recipient.
   Lancet. 2024;403:e1.
   

   >> Share

   
   December 2023
3. TUTTLE KR, Hauske SJ, Canziani ME, Caramori ML, et al
   Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial.
   Lancet. 2023 Dec 15:S0140-6736(23)02408-X. doi: 10.1016/S0140-6736(23)02408.
   

   >> Share

   
   November 2023
4. HEERSPINK HJL, Kiyosue A, Wheeler DC, Lin M, et al
   Zibotentan in combination with dapagliflozin compared with dapagliflozin in patients with chronic kidney disease (ZENITH-CKD): a multicentre, randomised, active-controlled, phase 2b, clinical trial.
   Lancet. 2023 Nov 2:S0140-6736(23)02230-4. doi: 10.1016/S0140-6736(23)02230.
   

   >> Share

   
   
5. ROVIN BH, Barratt J, Heerspink HJL, Alpers CE, et al
   Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
   Lancet. 2023 Nov 2:S0140-6736(23)02302-4. doi: 10.1016/S0140-6736(23)02302.
   

   >> Share

   
   August 2023
6. HASSAN HA, Hafez MH, Luyckx VA, Tuglular S, et al
   Kidney failure in Sudan: thousands of lives at risk.
   Lancet. 2023;402:607.
   

   >> Share

   
   March 2023
7. LUNDBERG S, Bergen K
   We can go further in non-immunosuppressive treatment of IgA nephropathy.
   Lancet. 2023 Mar 31:S0140-6736(23)00630-X. doi: 10.1016/S0140-6736(23)00630.
   

   >> Share

   
   January 2023
8. BUDDE K, Halleck F
   Six pills less: no benefit for bicarbonate supplementation in renal allograft recipients.
   Lancet. 2023 Jan 25:S0140-6736(22)02630-7. doi: 10.1016/S0140-6736(22)02630.
   

   >> Share

   
   
9. KOVALCHUK B, Khoramnia R
   Focusing on the eye signs of Alport syndrome in a 40-year-old man who previously had a kidney transplant and hearing loss.
   Lancet. 2023;401:e1.
   

   >> Share

   
   November 2022
10. SELBY NM, Taal MW
    Evaluating the results of MyTEMP, a cluster randomised trial of lower temperature haemodialysis: the end of a cool idea?
    Lancet. 2022;400:1657-1659.
    

    >> Share

    
    
11. MARK PB, Sattar N
    Implementation, not hesitation, for SGLT2 inhibition as foundational therapy for chronic kidney disease.
    Lancet. 2022 Nov 4. pii: S0140-6736(22)02164.
    

    >> Share

    
    September 2022
12. FAUCON AL, Messai N, Pardon A
    A sweet unilateral pleural effusion: pleuro-peritoneal communication in a patient on dialysis.
    Lancet. 2022;400:920.
    

    >> Share

    
    January 2022
13. TONELLI M, Thadhani R
    Anaemia in chronic kidney disease: what do new generation agents offer?
    Lancet. 2022 Jan 25. pii: S0140-6736(22)00120.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share